Switch to:
More From Other Websites
3 Stories To Watch At The Year’s Biggest Cancer Conference May 28 2016
7:01 am AbbVie confirms CHMP positive opinion for Humira to treat certain forms of non-infectious... May 28 2016
[$$] Once-Monthly MS Injection Approved in U.S. May 27 2016
Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (Daclizumab) for Multiple... May 27 2016
Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (daclizumab) for Multiple... May 27 2016
Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (Daclizumab) for Multiple... May 27 2016
Biogen, AbbVie once-monthly MS injection wins U.S. approval May 27 2016
Biogen, AbbVie once-monthly MS injection wins U.S. FDA approval May 27 2016
Morning Technical Breakdown Highlights on Big Drug Makers Stocks May 27 2016
AbbVie's HUMIRA Gets EU Regulator's Positive Opinion To Treat Some Non-Infectious Uveities Types May 27 2016
AbbVie's HUMIRA® (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of... May 27 2016
Investors Eager for Gilead to Make Big Moves May 26 2016
High-grade issuance tally for May now at new monthly record May 26 2016
The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie May 26 2016
AbbVie to Present at the Jefferies 2016 Healthcare Conference May 26 2016
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well May 25 2016
4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends May 25 2016
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data May 25 2016
Short Sellers Take Mixed Stance on Major Pharma May 25 2016
Richard Bernstein: Why Nobody Wants to Play May 24 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK